TelyRx Finco Inc. — Form D

TelyRx Finco Inc. of Toronto, A6, a company, filed a Form D exempt-offering notice with the SEC on 2026-04-20. The offering totals $12.6M, of which $12.6M was reported sold. Industry: Pharmaceuticals.

Offering

• Filed: 2026-04-20
• Form: D
• Accession: 0000912282-26-000629
• Industry: Pharmaceuticals
• Exemptions: 06b
• Total offering: $12.6M
• Amount sold: $12.6M
• Investors: 51
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-581152

Issuer

• Name: TelyRx Finco Inc.
• CIK: 0002125491
• Entity type: Corporation
• Jurisdiction: ONTARIO, CANADA
• Address: 333 Bay Street, Suite 2400, Toronto, A6, M5H 2T6
• Phone: 800-878-1660

Officers, directors & promoters (2)

More

• CIK 2125491 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search